Trials Differ On Safety Of Treating Heart Attacks With Drug-Eluting Stents
This article was originally published in The Gray Sheet
Executive Summary
Two new studies offer differing conclusions on the benefits of drug-eluting stent treatments in patients who have suffered a heart attack
You may also be interested in...
In An Emergency, Value Of Drug-Eluting Stents Still Questionable, Docs Say
More data is needed before drug-eluting stents should be considered for routine use as part of emergency treatment for a heart attack, according to an editorial in the Sept. 14 New England Journal of Medicine
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”